Trial Metric Retatrutide 12mg (TRIUMPH-4) Semaglutide 2.4mg (STEP 1) Mean Weight Loss 28.7% at 68 weeks 14.9% at 68 weeks Mechanism Triple agonist (GLP-1/GIP/GCGR) Single agonist (GLP-1) FDA Status Phase 3 (investigational) Approved (Wegovy) Dosing Weekly subcutaneous Weekly subcutaneous Common Adverse Events GI (nausea, vomiting, diarrhea), dysesthesia GI (nausea, vomiting, diarrhea) Important caveat: These results come from different trial populations and study designs
Think fat loss, not muscle If it fits into your budget, a bathroom or home scale which estimates your body fat and muscle percentage can be helpful
If youre interested in finding an alternative to Januvia, talk with your doctor
Berry M, Morgan A, Shaw DE, et al
Yeung, A
Clean the injection site with an alcohol wipe and allow it to dry completely